This site is intended for health professionals only
Saturday 15 December 2018
Share |

Latest News

Collaborative discovery of microbiome-based biomarkers for IBD

Thursday 13th December 2018
BiomX Ltd, a microbiome company developing customised phage therapies,  has entered into a collaboration with Janssen Research & Development to utilise BiomX’s XMarker microbiome-based biomarker discovery platform. The XMarker platform will be used to stratify responders and non-responders to inflammatory bowel disease (IBD) therapeutics.
The collaboration was facilitated by Johnson & Johnson Innovation Limited....
Wed, 12 Dec 2018
The Government has chosen England’s chief pharmacist to look into ‘problematic’ overprescribing in the NHS, it has announced.
Tue, 11 Dec 2018
A no-deal Brexit could create disruption over importing and exporting medicines at the Anglo-French border for up to six months, the Government has predicted.
Mon, 10 Dec 2018
The Joint Cancer Research UK - AstraZeneca Functional Genomics Centre will be a dedicated world-class resource for AstraZeneca and Cancer Research UK’s academics and alliance partners working at all stages of translational research, from target discovery and validation, to assessing novel drug combinations
Fri, 7 Dec 2018
Novartis's BYL719 is in late-stage development, and Qiagen expects to provide its companion diagnostic to clinical laboratory partners who will then be ready to offer immediate access to the test upon potential regulatory approvals
Thu, 6 Dec 2018
Leading academics and health data specialists have formed an alliance to boost science and innovation in the UK
Thu, 6 Dec 2018
Delays in taking new cancer drugs through clinical trials and getting them approved for use mean NHS patients are waiting longer to access them, a report by the Institute of Cancer Research (ICR) finds.
Thu, 6 Dec 2018
Research shows 31% of medication administration errors in English and Welsh acute care trusts are due to omitted medicine or ingredient.